Inter Biosolutions ApS: Financial statements 2023
CVR: 43014757
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Inter Biosolutions ApS (CVR 43014757) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -18,750 and a net result of DKK -14,614 compared with DKK -8,311 the year before. Equity in the 2023 report amounted to DKK 19,075. The solvency ratio was 15.7%.
- Revenue
- DKK 0
- Gross Profit
- DKK -18,750
- Profit/Loss
- DKK -14,614
- Equity
- DKK 19,075
- Total Assets
- DKK 121,122
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | -19 t. | -15 t. | 19 t. | - |
| 2022 | 0 | -8 t. | -8 t. | 34 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Inter Biosolutions ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -8,311.
About Inter Biosolutions ApS
Inter Biosolutions ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Inter Biofuel ApS. The management consists of Klaus Hjortenberg Kroll. The company is owned by STEEN BRUMMERSTEDT IVERSEN ApS and Kobo ApS. In 2025, the company reported a gross profit of DKK 1,732,251 and a net result of DKK -1,516,000 compared with DKK -485,946 the year before. Equity in the 2025 report amounted to DKK 1,017,129.